Teyi Pharmaceutical Group Co.,Ltd

SZSE:002728 Stock Report

Market Cap: CN¥3.9b

Teyi Pharmaceutical GroupLtd Past Earnings Performance

Past criteria checks 2/6

Teyi Pharmaceutical GroupLtd has been growing earnings at an average annual rate of 10.2%, while the Pharmaceuticals industry saw earnings growing at 9.2% annually. Revenues have been growing at an average rate of 2.8% per year. Teyi Pharmaceutical GroupLtd's return on equity is 7.8%, and it has net margins of 16.9%.

Key information

10.2%

Earnings growth rate

6.0%

EPS growth rate

Pharmaceuticals Industry Growth10.9%
Revenue growth rate2.8%
Return on equity7.8%
Net Margin16.9%
Next Earnings Update19 Jul 2024

Recent past performance updates

Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems

Apr 26
Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems

Recent updates

We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Can Stay On Top Of Its Debt

Jun 06
We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Can Stay On Top Of Its Debt

Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems

Apr 26
Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems

Teyi Pharmaceutical Group Co.,Ltd's (SZSE:002728) Shares Bounce 29% But Its Business Still Trails The Market

Mar 06
Teyi Pharmaceutical Group Co.,Ltd's (SZSE:002728) Shares Bounce 29% But Its Business Still Trails The Market

Here's Why We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Is Well Worth Watching

Feb 27
Here's Why We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Is Well Worth Watching

Revenue & Expenses Breakdown

How Teyi Pharmaceutical GroupLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:002728 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2492815724444
31 Dec 231,06725324143
30 Sep 231,04926922543
31 Mar 2399623819640
31 Dec 2288717817738
30 Sep 2281612217539
30 Jun 2278511316938
31 Mar 2275813116138
01 Jan 2275812717838
30 Sep 2172511815937
30 Jun 216919215838
31 Mar 216526315937
31 Dec 206334415336
30 Sep 206686620038
30 Jun 2074310822339
31 Mar 2085215524642
31 Dec 1992117226744
30 Sep 1993916829242
30 Jun 1994917127449
31 Mar 1992617126448
31 Dec 1888515625847
30 Sep 1882814620856
30 Jun 1877712817766
31 Mar 1873911216156
31 Dec 1768710614946
30 Sep 1768911016027
30 Jun 176801051900
31 Mar 17650941930
31 Dec 16656951870
30 Sep 16648851840
30 Jun 16631841760
31 Mar 16584801610
31 Dec 15517811390
30 Sep 1541978940
30 Jun 1535674770
31 Mar 1535578680
31 Dec 1434580660
30 Sep 1434782620
30 Jun 1434585830
31 Mar 1433782690
31 Dec 1334381560

Quality Earnings: 002728 has high quality earnings.

Growing Profit Margin: 002728's current net profit margins (16.9%) are lower than last year (23.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 002728's earnings have grown by 10.2% per year over the past 5 years.

Accelerating Growth: 002728's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 002728 had negative earnings growth (-34.1%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-0.8%).


Return on Equity

High ROE: 002728's Return on Equity (7.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.